Form 4: OrbiMed Advisors Reduces Stake in Xtant Medical Holdings

OrbiMed Advisors LLC and related entities report the sale of common stock in Xtant Medical Holdings, Inc., resulting in adjustments to their beneficial ownership.

Summary

• OrbiMed Advisors LLC, along with related entities ROS Acquisition Offshore LP and OrbiMed Royalty Opportunities II, LP, filed a Form 4 detailing changes in beneficial ownership of Xtant Medical Holdings, Inc. (XTNT) common stock.
• On April 10, 2025, ROS Acquisition Offshore LP disposed of 56,004,974 shares at a price of $0.42 per share.
• On the same date, OrbiMed Royalty Opportunities II, LP disposed of 17,109,618 shares at $0.42 per share.
• Following these transactions, the entities still indirectly own shares of Xtant Medical Holdings, Inc.
• OrbiMed Advisors disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest.

Sentiment

Score: 5

Explanation: Neutral sentiment as it reflects a standard transaction disclosure. The impact on the company's stock price will depend on market perception.

Negatives

• OrbiMed Advisors reduced its stake in Xtant Medical Holdings, which could be perceived negatively by investors.

Risks

• The reduction in OrbiMed's stake could indicate a change in their investment outlook for Xtant Medical Holdings.
• The market may react negatively to the news of a major shareholder reducing their position.

Management Comments

• Carl L. Gordon, Member of OrbiMed Advisors LLC and OrbiMed ROF II LLC, signed the report.

Industry Context

Form 4 filings are standard disclosures required by the SEC when significant changes occur in the ownership of a company's securities by its insiders or major shareholders. This filing indicates a change in OrbiMed's investment in Xtant Medical Holdings.

Comparison to Industry Standards

• It's common for investment firms like OrbiMed to adjust their holdings in portfolio companies based on their investment strategies and market conditions.
• Similar transactions are regularly observed across the healthcare and biotechnology sectors, where investment firms actively manage their positions in companies.

Stakeholder Impact

• Shareholders may react to the news of OrbiMed reducing its stake.
• The company's management may need to address investor concerns regarding the change in ownership.

Key Dates

Keywords

Xtant Medical Holdings, OrbiMed Advisors, ROS Acquisition Offshore LP, OrbiMed Royalty Opportunities II LP, Beneficial Ownership, Form 4, Stock Sale